Skip to content

Impact of GLUBLOC™ on healthy individuals

Impact of GLUBLOC™ on postprandial blood glucose and insulin levels in healthy individuals post high carb meal intake

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052654
Enrollment
100
Registered
2023-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: GLUBLOC Morus alba and Malus domestica: 500mg/ Day Total Duration 2 days (Day 1 and Day 5) Control Intervention1: Placebo Vitamin C: 500mg/day Total Duration 2 days (Day 1 and Day 5)

Sponsors

My Pura Vida Wellness Private Limited (Puravida)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Aged between 18–60 years, 2.BMI between 18.5 and 22.9 kg/m2 3.Fasting blood glucose range between 3.9 and 5.5 mmol/L

Exclusion criteria

Exclusion criteria: 1.Women who were pregnant or lactating 2.Any known food allergies 3.Subjects with a bleeding disorder 4.Pre-existing medical condition or taking medication known to affect glucose regulation and/or influence digestion and absorption of nutrients 5. History of diabetes mellitus (type I/II) or they used antihyperglycaemic drugs or insulin to treat diabetes or related conditions 6.Used steroids, protease inhibitors or antipsychotic medicines as these drugs are known to impact glucose metabolism and body fat distribution. 7. Refused consent

Design outcomes

Primary

MeasureTime frame
To document the impact of GLUBLOC™ supplementation on postprandial changes in plasma glucose and insulin in post-high carbohydrate mealTimepoint: Blood sample pre-intervention - Baseline sample 0 Hrs Post-intervention - 15, 30,45,60,90,120,150,180 minutes

Secondary

MeasureTime frame
To document the sensitivity and specificity of GLUBLOC supplementation in healthy individuals post high carb meal intakeTimepoint: Blood sample pre-intervention - Baseline sample 0 Hrs Post-intervention - 15, 30,45,60,90,120,150,180 minutes

Countries

India

Contacts

Public ContactBalamurugan Ramadass

AIIMS, Bhubaneswar

balaramadass1@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026